Royal Bank Of Canada Pro Mis Neurosciences Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 5,487 shares of PMN stock, worth $3,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,487
Previous 5,487
-0.0%
Holding current value
$3,731
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
8.47MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.65MShares$1.8 Million1.05% of portfolio
-
Armistice Capital, LLC New York, NY2.14MShares$1.45 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.9MShares$1.29 Million0.25% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.33MShares$907,4110.92% of portfolio
-
Allostery Investments LP Stamford, CT156KShares$105,8890.97% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...